156 related articles for article (PubMed ID: 32369961)
1. Synthetic Hydroxyapatite Inhibits Bisphosphonate Toxicity to the Oral Mucosa In Vitro.
Bullock G; Miller C; McKechnie A; Hearnden V
Materials (Basel); 2020 May; 13(9):. PubMed ID: 32369961
[TBL] [Abstract][Full Text] [Related]
2.
Rattanawonsakul K; Bullock G; Bolt R; Claeyssens F; Atkins S; Hearnden V
Front Oral Health; 2022; 3():892615. PubMed ID: 35795156
[TBL] [Abstract][Full Text] [Related]
3. A Review Into the Effects of Pamidronic Acid and Zoledronic Acid on the Oral Mucosa in Medication-Related Osteonecrosis of the Jaw.
Bullock G; Miller CA; McKechnie A; Hearnden V
Front Oral Health; 2021; 2():822411. PubMed ID: 35224540
[TBL] [Abstract][Full Text] [Related]
4. Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice.
Hokugo A; Kanayama K; Sun S; Morinaga K; Sun Y; Wu Q; Sasaki H; Okawa H; Evans C; Ebetino FH; Lundy MW; Sadrerafi K; McKenna CE; Nishimura I
Bone; 2019 Jun; 123():115-128. PubMed ID: 30926440
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of bisphosphonate-related osteonecrosis of the jaw-like lesions is increased in a chemotherapeutic dose-dependent manner in mice.
Kuroshima S; Sasaki M; Nakajima K; Tamaki S; Hayano H; Sawase T
Bone; 2018 Jul; 112():177-186. PubMed ID: 29729428
[TBL] [Abstract][Full Text] [Related]
6. Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.
Kuroshima S; Sasaki M; Murata H; Sawase T
Gerodontology; 2019 Dec; 36(4):313-324. PubMed ID: 31373407
[TBL] [Abstract][Full Text] [Related]
7. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
8. Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: A systematic review and meta-analysis.
Limones A; Sáez-Alcaide LM; Díaz-Parreño SA; Helm A; Bornstein MM; Molinero-Mourelle P
Med Oral Patol Oral Cir Bucal; 2020 May; 25(3):e326-e336. PubMed ID: 32271321
[TBL] [Abstract][Full Text] [Related]
9. In vitro synergistic effects of zoledronic acid and calcium on viability of human epithelial cells.
Arai N; Inoue S; Tomihara K; Tsuno H; Noguchi M
Oral Dis; 2013 Mar; 19(2):200-5. PubMed ID: 22891943
[TBL] [Abstract][Full Text] [Related]
10. Bony changes in the jaws of rats treated with zoledronic acid and dexamethasone before dental extractions mimic bisphosphonate-related osteonecrosis in cancer patients.
Sonis ST; Watkins BA; Lyng GD; Lerman MA; Anderson KC
Oral Oncol; 2009 Feb; 45(2):164-72. PubMed ID: 18715819
[TBL] [Abstract][Full Text] [Related]
11. Bisphosphonate-Related Osteonecrosis of the Jaw (BRONJ) therapy. A critical review.
Vescovi P; Nammour S
Minerva Stomatol; 2010 Apr; 59(4):181-203, 204-13. PubMed ID: 20360666
[TBL] [Abstract][Full Text] [Related]
12. Adipose-derived stem cells prevent the onset of bisphosphonate-related osteonecrosis of the jaw through transforming growth factor β-1-mediated gingival wound healing.
Zang X; He L; Zhao L; He Y; Xiao E; Zhang Y
Stem Cell Res Ther; 2019 Jun; 10(1):169. PubMed ID: 31196208
[TBL] [Abstract][Full Text] [Related]
13. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
[TBL] [Abstract][Full Text] [Related]
14. Further development of the MRONJ minipig large animal model.
Otto S; Pautke C; Martin Jurado O; Nehrbass D; Stoddart MJ; Ehrenfeld M; Zeiter S
J Craniomaxillofac Surg; 2017 Sep; 45(9):1503-1514. PubMed ID: 28803745
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic effects of zoledronic acid on human epithelial cells and gingival fibroblasts.
Basso FG; Pansani TN; de Oliveira CF; Turrioni AP; Soares DG; Hebling J; Costa CA
Braz Dent J; 2013; 24(6):551-8. PubMed ID: 24474348
[TBL] [Abstract][Full Text] [Related]
16. Imaging modalities for drug-related osteonecrosis of the jaw (2), Overview of the position paper on medication-related osteonecrosis of the jaw and the current status of the MRONJ in Japan.
Shibahara T
Jpn Dent Sci Rev; 2019 Nov; 55(1):71-75. PubMed ID: 30949254
[TBL] [Abstract][Full Text] [Related]
17. Calcium Phosphate Ceramics Can Prevent Bisphosphonate-Related Osteonecrosis of the Jaw.
Paulo S; Laranjo M; Paula A; Abrantes AM; Martins J; Marto CM; Coelho A; Casalta-Lopes J; Carvalho L; Carrilho E; Serra A; Botelho MF; Marques Ferreira M
Materials (Basel); 2020 Apr; 13(8):. PubMed ID: 32331240
[TBL] [Abstract][Full Text] [Related]
18. Effect of different doses of zoledronic acid in establishing of bisphosphonate-related osteonecrosis.
Silva PG; Ferreira Junior AE; Teófilo CR; Barbosa MC; Lima Júnior RC; Sousa FB; Mota MR; Ribeiro Rde A; Alves AP
Arch Oral Biol; 2015 Sep; 60(9):1237-45. PubMed ID: 26093347
[TBL] [Abstract][Full Text] [Related]
19. Epidermal Growth Factor Reverses the Inhibitory Effects of the Bisphosphonate, Zoledronic Acid, on Human Oral Keratinocytes and Human Vascular Endothelial Cells In Vitro via the Epidermal Growth Factor Receptor (EGFR)/Akt/Phosphoinositide 3-Kinase (PI3K) Signaling Pathway.
Wang Q; Liu J; Guo T; Liu D; Pan J
Med Sci Monit; 2019 Jan; 25():700-710. PubMed ID: 30675875
[TBL] [Abstract][Full Text] [Related]
20. Zoledronic acid promotes TLR-4-mediated M1 macrophage polarization in bisphosphonate-related osteonecrosis of the jaw.
Zhu W; Xu R; Du J; Fu Y; Li S; Zhang P; Liu L; Jiang H
FASEB J; 2019 Apr; 33(4):5208-5219. PubMed ID: 30624969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
